HA-VHL T157I-pBabe-puro
(Plasmid
#19240)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 19240 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneHA-pBabe-puro
- Backbone size w/o insert (bp) 5202
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namevon Hippel-Lindau tumor suppressor (VHL)
-
Alt namevHL
-
SpeciesH. sapiens (human)
-
Insert Size (bp)652
-
Mutationchanged Threonin 157 to Isoleucin
-
GenBank IDNM_000551
-
Entrez GeneVHL (a.k.a. HRCA1, RCA1, VHL1, pVHL)
-
Tag
/ Fusion Protein
- HA-tag (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH I (not destroyed)
- 3′ cloning site EcoR I (not destroyed)
- 5′ sequencing primer pBabe-5'
- 3′ sequencing primer pBabe-3' (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
HA-VHL T157I-pBabe-puro was a gift from William Kaelin (Addgene plasmid # 19240 ; http://n2t.net/addgene:19240 ; RRID:Addgene_19240) -
For your References section:
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Li L, Zhang L, Zhang X, Yan Q, Minamishima YA, Olumi AF, Mao M, Bartz S, Kaelin WG. Mol Cell Biol. 2007 Aug . 27(15):5381-92. 10.1128/MCB.00282-07 PubMed 17526729